abstract |
The present invention relates to fused bicyclic metalloproteinase inhibitors of the formula n n n wherein A, B, X, Y, and R 1 are as defined in the specification, and to pharmaceutical compositions and methods of treating arthritis, inflammation, cancer and other disorders. |